ALEXION PHARMACEUTICALS INC's ticker is and the CUSIP is 15351109. A total of 16 filers reported holding ALEXION PHARMACEUTICALS INC in Q2 2015. The put-call ratio across all filers is 0.12 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $13,828,000 | -10.2% | 112,844 | -14.4% | 2.17% | -2.8% |
| Q2 2016 | $15,391,000 | -18.2% | 131,818 | -2.5% | 2.24% | -17.8% |
| Q1 2016 | $18,819,000 | -2.5% | 135,175 | +33.6% | 2.72% | +5.5% |
| Q4 2015 | $19,299,000 | +30.6% | 101,173 | +7.1% | 2.58% | +13.6% |
| Q3 2015 | $14,773,000 | +0.4% | 94,460 | +16.1% | 2.27% | -8.3% |
| Q2 2015 | $14,709,000 | +38.1% | 81,367 | +32.3% | 2.47% | +46.5% |
| Q1 2015 | $10,654,000 | -14.4% | 61,479 | -8.6% | 1.69% | -13.5% |
| Q4 2014 | $12,440,000 | +2.7% | 67,230 | -8.0% | 1.95% | +7.4% |
| Q3 2014 | $12,114,000 | +1.6% | 73,056 | -4.2% | 1.82% | +5.1% |
| Q2 2014 | $11,920,000 | +16.5% | 76,291 | +13.4% | 1.73% | +1.9% |
| Q1 2014 | $10,234,000 | +34.0% | 67,272 | +17.1% | 1.70% | +17.6% |
| Q4 2013 | $7,635,000 | +31.2% | 57,455 | +14.7% | 1.44% | +6.7% |
| Q3 2013 | $5,818,000 | +33.4% | 50,089 | +5.9% | 1.35% | +5.5% |
| Q2 2013 | $4,361,000 | – | 47,283 | – | 1.28% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|